Analyzing cancer genomic data to improve treatment strategies
OHSU Center for Specialized Data Analysis as part of the GDAN
['FUNDING_OTHER'] · OREGON HEALTH & SCIENCE UNIVERSITY · NIH-10911970
This study is looking at how different people with cancer respond to treatments, so we can find better, personalized therapies that work best for them.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | OREGON HEALTH & SCIENCE UNIVERSITY (nih funded) |
| Locations | 1 site (PORTLAND, UNITED STATES) |
| Trial ID | NIH-10911970 on ClinicalTrials.gov |
What this research studies
This research focuses on understanding the mechanisms behind cancer treatment responses and resistance, aiming to identify specific patient subsets that would benefit from targeted therapies. By leveraging advanced data analysis techniques and the expertise of a multidisciplinary team, the project seeks to enhance the capabilities of the Genomic Data Analysis Network (GDAN). The team will utilize data from previous successful initiatives like The Cancer Genome Atlas (TCGA) to develop innovative approaches for analyzing cancer genomics. Patients may benefit from improved treatment strategies tailored to their unique cancer profiles.
Who could benefit from this research
Good fit: Ideal candidates for this research include patients with metastatic cancers who are seeking targeted therapies.
Not a fit: Patients with early-stage cancers or those not undergoing treatment may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized cancer treatments for patients.
How similar studies have performed: Previous research initiatives like The Cancer Genome Atlas have shown significant success in improving cancer treatment through genomic data analysis.
Where this research is happening
PORTLAND, UNITED STATES
- OREGON HEALTH & SCIENCE UNIVERSITY — PORTLAND, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ELLROTT, KYLE — OREGON HEALTH & SCIENCE UNIVERSITY
- Study coordinator: ELLROTT, KYLE
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancer Biology, Cancer Center, Cancers